中文产业新闻评分60Chinese source
礼来非共价BTK抑制剂匹妥布替尼在华获批慢性淋巴细胞白血病/小淋巴细胞淋巴瘤初治适应症
非共价BTK抑制剂首次进入一线!
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
非共价BTK抑制剂首次进入一线!
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.